This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schneider, A. Articles by Gaub, M. P. Search for Related Content PubMed PubMed Citation Articles by Schneider, A. Articles by Gaub, M. P.

Evaluation of Microsatellite Analysis in Urine Sediment for Diagnosis of Bladder Cancer¹

Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital de Hautepierre [A. S., O. R., P. O., M. P. G.], Service de Chirurgie Urologique [S. B., H. L., C. S., D. J.], and Institut d’Anatomie Pathologique [V. L., M. K.], Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France

Alterations at microsatellite DNA markers in cells exfoliated in urine have been correlated to the presence of bladder cancer. To check the feasibility of such noninvasive analysis to routinely diagnose bladder cancers, we have developed a highly sensitive method using fluorescent PCR to search for DNA microsatellite alterations in urine sediment compared with a blood paired sample. One hundred eighty-three patients were included in our study. This population comprised 103 bladder cancers (64 pT_a stages), the complement representing controls and other benign or malignant diseases. Results of the analysis at 17 loci in a blinded study were compared with cystoscopy and/or pathology. The high reproducibility of this technique and the analysis of 26 control patients allowed us to determine for each microsatellite a cutoff characterizing a significant allelic imbalance. For bladder cancer detection, the overall sensitivity of the test was 84%. Using this procedure, we identified alterations in 81%, 84%, 91%, and 100% of pT_a, pT₁, pT₂, and >pT₂ stages, respectively. This corresponds to 79%, 82%, and 96% sensitivity for grades I, II, and III, respectively. Interestingly, for routine purposes, we observed an overall sensitivity of 80% (76% for pT_a stages) when only the eight most rearranged microsatellites were considered. In conclusion, the noninvasive feature combined with the rapidity of this fluorescent and highly sensitive technique for the detection of early stages provides us with a useful help for the diagnosis of bladder cancer.

This article has been cited by other articles:

				N. Entz-Werle, L. Marcellin, M.-P. Gaub, E. Guerin, A. Schneider, P. Berard-Marec, C. Kalifa, L. Brugiere, H. Pacquement, C. Schmitt, et al. Prognostic Significance of Allelic Imbalance at the c-kit Gene Locus and c-kit Overexpression by Immunohistochemistry in Pediatric Osteosarcomas J. Clin. Oncol., April 1, 2005; 23(10): 2248 - 2255. [Abstract] [Full Text] [PDF]

				M. O. Hoque, J. Lee, S. Begum, K. Yamashita, J. M. Engles, M. Schoenberg, W. H. Westra, and D. Sidransky High-Throughput Molecular Analysis of Urine Sediment for the Detection of Bladder Cancer by High-Density Single-Nucleotide Polymorphism Array Cancer Res., September 15, 2003; 63(18): 5723 - 5726. [Abstract] [Full Text] [PDF]

				B. J. Duggan, J. J. McKnight, K. E. Williamson, M. Loughrey, D. O'Rourke, P. W. Hamilton, S. R. Johnston, C. C. Schulman, and A. R. Zlotta The Need to Embrace Molecular Profiling of Tumor Cells in Prostate and Bladder Cancer Clin. Cancer Res., April 1, 2003; 9(4): 1240 - 1247. [Abstract] [Full Text] [PDF]

				M. Sanchez-Carbayo Use of High-Throughput DNA Microarrays to Identify Biomarkers for Bladder Cancer Clin. Chem., January 1, 2003; 49(1): 23 - 31. [Abstract] [Full Text] [PDF]

				B. W. G. van Rhijn, I. Lurkin, D. K. Chopin, W. J. Kirkels, J.-P. Thiery, T. H. van der Kwast, F. Radvanyi, and E. C. Zwarthoff Combined Microsatellite and FGFR3 Mutation Analysis Enables a Highly Sensitive Detection of Urothelial Cell Carcinoma in Voided Urine Clin. Cancer Res., January 1, 2003; 9(1): 257 - 263. [Abstract] [Full Text] [PDF]

				F. Cave-Riant, B. Cuillerier, M. Beau-Faller, N. Martinet, F. Alla, C. Bronner, A. Schneider, P. Oudet, and M. P. Gaub Association of Genetic Defects in Primary Resected Lung Adenocarcinoma Revealed by Targeted Allelic Imbalance Analysis Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 495 - 502. [Abstract] [Full Text] [PDF]

				R. Miturski, M. Bogusiewicz, C. Ciotta, M. Bignami, M. Gogacz, and D. Burnouf Mismatch Repair Genes and Microsatellite Instability as Molecular Markers for Gynecological Cancer Detection Exp Biol Med, September 1, 2002; 227(8): 579 - 586. [Abstract] [Full Text] [PDF]

				J. Little, L. Bradley, M. S. Bray, M. Clyne, J. Dorman, D. L. Ellsworth, J. Hanson, M. Khoury, J. Lau, T. R. O'Brien, et al. Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations Am. J. Epidemiol., August 15, 2002; 156(4): 300 - 310. [Abstract] [Full Text] [PDF]